CIK 0001088856 · Large accelerated filer
CORCEPT THERAPEUTICS INC
Sign in to watch- Ticker
- CORT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770487658
- Phone
- 650.688.8803
- Business address
- 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,067,988
- in 15 filings, $36.6M under 10b5-1 plans
Net −$41,067,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-01 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −5,823 | $67.51 | $393K | 10,066 |
| 2025-08-01 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −5,823 | 31,571 | ||
| 2025-07-18 | Maduck Sean See Remarks | Option exercise 10b5-1 | +473 | $5.05 | $2K | 18,178 |
| 2025-07-18 | Maduck Sean See Remarks | Sale 10b5-1 | −473 | $73.44 | $35K | 17,705 |
| 2025-07-18 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −473 | 56,993 | ||
| 2025-07-18 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +200 | $13.56 | $3K | 10,266 |
| 2025-07-18 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −200 | $73.40 | $15K | 10,066 |
| 2025-07-18 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −200 | 37,394 | ||
| 2025-07-18 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +500 | $21.65 | $11K | 5,987 |
| 2025-07-18 | Guyer William Chief Development Officer | Sale 10b5-1 | −500 | $73.44 | $37K | 5,487 |
| 2025-07-18 | Guyer William Chief Development Officer | Option exercise · Stock option (right to buy) 10b5-1 | −500 | 385,021 | ||
| 2025-07-17 | Maduck Sean See Remarks | Option exercise 10b5-1 | +4,315 | $5.05 | $22K | 22,020 |
| 2025-07-17 | Maduck Sean See Remarks | Sale 10b5-1 | −4,315 | $73.48 | $317K | 17,705 |
| 2025-07-17 | Maduck Sean See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −4,315 | 57,466 | ||
| 2025-07-17 | BELANOFF JOSEPH K Chief Executive Officer | Sale 10b5-1 | −615 | $73.69 | $45K | 2,901,370 |
| 2025-07-17 | Lyon Joseph Douglas See Remarks | Option exercise 10b5-1 | +3,877 | $13.56 | $53K | 13,943 |
| 2025-07-17 | Lyon Joseph Douglas See Remarks | Sale 10b5-1 | −3,877 | $73.48 | $285K | 10,066 |
| 2025-07-17 | Lyon Joseph Douglas See Remarks | Option exercise · Stock option (right to buy) 10b5-1 | −3,877 | 37,594 | ||
| 2025-07-17 | Guyer William Chief Development Officer | Option exercise 10b5-1 | +4,379 | $21.65 | $95K | 9,866 |
| 2025-07-17 | Guyer William Chief Development Officer | Sale 10b5-1 | −4,379 | $73.48 | $322K | 5,487 |
Page 22 of 61 · 1,220 trades